QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: EVDAS and Signal Detection in Pharmacovigilance

Test your understanding of the concepts covered by EVDAS and Signal Detection in Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which sequence best represents the structured handling of a potential safety signal?

Communication, detection, closure, validation and assessment Detection, validation, assessment and appropriate decision or action Assessment, detection, regulatory submission and validation Validation, routine reporting, detection and automatic escalation

Question 2 of 10 In the worked example, which combination most strongly supported escalation of the MedX–SSRx finding to the SRT?

A low case count, no serious outcomes and no temporal pattern Serious cases including a fatality, temporal plausibility and biopsy confirmation in some cases A high PRR alone, without case-level review Reports confined to one case with a clear alternative cause

Question 3 of 10 Why should signal-management governance be reflected in the PSMF?

To replace the need for operational SOPs To identify where signal detection fits organisationally and define current roles, committees and reporting lines To record only the statistical thresholds used in EVDAS To ensure that all signals remain confidential from internal governance bodies

Question 4 of 10 Which activity is most characteristic of signal assessment rather than initial triage?

Checking whether the eRMR extract contains its data lock point Assigning a unique identifier to the signal record Conducting epidemiological analyses and considering benefit-risk or risk-minimisation implications Confirming that the report was archived in a read-only location

Question 5 of 10 What is the most appropriate role of a multidisciplinary Signal Review Team?

To perform database maintenance without making safety decisions To review validated concerns using relevant medical, scientific, regulatory and quality perspectives and recommend actions To replace the QPPV's overall responsibility for the pharmacovigilance system To approve all disproportionality results without considering case details

Question 6 of 10 Which documentation set provides the strongest traceability for an eRMR-derived potential signal?

The eRMR alone, without review notes or decisions The eRMR, triage rationale, medical validation, committee decisions, actions and closure or escalation rationale A verbal summary from the analyst and an unapproved presentation Only the final regulatory communication

Question 7 of 10 Which description most accurately reflects the status of a safety signal?

It is a hypothesis suggesting a potentially causal association that warrants investigation It is a confirmed adverse drug reaction requiring immediate withdrawal It is any individual case report regardless of clinical relevance It is a statistical result that is automatically accepted after database extraction

Question 8 of 10 Which factor would most directly help distinguish a meaningful reporting pattern from a transient statistical fluctuation?

Whether the report was generated using a current template only Whether reporting increases are sustained over time and clinically plausible Whether the product has been authorised for more than five years Whether the event has a preferred term in the database

Question 9 of 10 Why might an organisation perform sensitivity analyses restricted to serious cases or EU cases?

To test whether the observed pattern persists under relevant alternative data definitions To guarantee that all remaining cases are causally related To remove the need for reviewing individual case narratives To convert a reporting ratio into an incidence rate

Question 10 of 10 Which statement best describes the relationship between signal closure and causality?

Closure always means the product has been proven not to cause the event Closure may reflect insufficient evidence, clarified confounding or another documented reason, with the rationale recorded A signal may be closed only after a product withdrawal Closure is prohibited whenever disproportionality is present

Knowledge Assessment: EVDAS and Signal Detection in Pharmacovigilance

Cookie Settings